On March 10, 2023, Virax Biolabs Group Limited closed the transaction. The company has received funding pursuant to Regulation D from one investor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.855 USD | +8.08% | +8.92% | -41.44% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.44% | 1.87M | |
+64.23% | 55.07B | |
-2.31% | 41.79B | |
+44.36% | 40.22B | |
-8.29% | 28.17B | |
+11.97% | 26.28B | |
-21.16% | 18.93B | |
+7.54% | 13.03B | |
+27.17% | 12.26B | |
+25.72% | 12.21B |
- Stock Market
- Equities
- VRAX Stock
- News Virax Biolabs Group Limited
- Virax Biolabs Group Limited announced that it has received $4.000001 million in funding